High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction

Gang Li, Marta Martínez-Bonet, Di Wu, Yu Yang, Jing Cui, Hung N. Nguyen, Pierre Cunin, Anaïs Levescot, Ming Bai, Harm Jan Westra, Yukinori Okada, Michael B. Brenner, Soumya Raychaudhuri, Eric A. Hendrickson, Richard L. Maas, Peter A. Nigrovic

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Genome-wide association studies (GWAS) have identified many disease-associated noncoding variants, but cannot distinguish functional single-nucleotide polymorphisms (fSNPs) from others that reside incidentally within risk loci. To address this challenge, we developed an unbiased high-throughput screen that employs type IIS enzymatic restriction to identify fSNPs that allelically modulate the binding of regulatory proteins. We coupled this approach, termed SNP-seq, with flanking restriction enhanced pulldown (FREP) to identify regulation of CD40 by three disease-associated fSNPs via four regulatory proteins, RBPJ, RSRC2 and FUBP-1/TRAP150. Applying this approach across 27 loci associated with juvenile idiopathic arthritis, we identified 148 candidate fSNPs, including two that regulate STAT4 via the regulatory proteins SATB2 and H1.2. Together, these findings establish the utility of tandem SNP-seq/FREP to bridge the gap between GWAS and disease mechanism.

Original languageEnglish (US)
Pages (from-to)1180-1188
Number of pages9
JournalNature Genetics
Volume50
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Single Nucleotide Polymorphism
Enzymes
Genome-Wide Association Study
Juvenile Arthritis
Carrier Proteins
Proteins

Cite this

Li, G., Martínez-Bonet, M., Wu, D., Yang, Y., Cui, J., Nguyen, H. N., ... Nigrovic, P. A. (2018). High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. Nature Genetics, 50(8), 1180-1188. https://doi.org/10.1038/s41588-018-0159-z

High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. / Li, Gang; Martínez-Bonet, Marta; Wu, Di; Yang, Yu; Cui, Jing; Nguyen, Hung N.; Cunin, Pierre; Levescot, Anaïs; Bai, Ming; Westra, Harm Jan; Okada, Yukinori; Brenner, Michael B.; Raychaudhuri, Soumya; Hendrickson, Eric A.; Maas, Richard L.; Nigrovic, Peter A.

In: Nature Genetics, Vol. 50, No. 8, 01.08.2018, p. 1180-1188.

Research output: Contribution to journalArticle

Li, G, Martínez-Bonet, M, Wu, D, Yang, Y, Cui, J, Nguyen, HN, Cunin, P, Levescot, A, Bai, M, Westra, HJ, Okada, Y, Brenner, MB, Raychaudhuri, S, Hendrickson, EA, Maas, RL & Nigrovic, PA 2018, 'High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction', Nature Genetics, vol. 50, no. 8, pp. 1180-1188. https://doi.org/10.1038/s41588-018-0159-z
Li, Gang ; Martínez-Bonet, Marta ; Wu, Di ; Yang, Yu ; Cui, Jing ; Nguyen, Hung N. ; Cunin, Pierre ; Levescot, Anaïs ; Bai, Ming ; Westra, Harm Jan ; Okada, Yukinori ; Brenner, Michael B. ; Raychaudhuri, Soumya ; Hendrickson, Eric A. ; Maas, Richard L. ; Nigrovic, Peter A. / High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. In: Nature Genetics. 2018 ; Vol. 50, No. 8. pp. 1180-1188.
@article{dc3724b190fb411c99ee8024b7e60b3c,
title = "High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction",
abstract = "Genome-wide association studies (GWAS) have identified many disease-associated noncoding variants, but cannot distinguish functional single-nucleotide polymorphisms (fSNPs) from others that reside incidentally within risk loci. To address this challenge, we developed an unbiased high-throughput screen that employs type IIS enzymatic restriction to identify fSNPs that allelically modulate the binding of regulatory proteins. We coupled this approach, termed SNP-seq, with flanking restriction enhanced pulldown (FREP) to identify regulation of CD40 by three disease-associated fSNPs via four regulatory proteins, RBPJ, RSRC2 and FUBP-1/TRAP150. Applying this approach across 27 loci associated with juvenile idiopathic arthritis, we identified 148 candidate fSNPs, including two that regulate STAT4 via the regulatory proteins SATB2 and H1.2. Together, these findings establish the utility of tandem SNP-seq/FREP to bridge the gap between GWAS and disease mechanism.",
author = "Gang Li and Marta Mart{\'i}nez-Bonet and Di Wu and Yu Yang and Jing Cui and Nguyen, {Hung N.} and Pierre Cunin and Ana{\"i}s Levescot and Ming Bai and Westra, {Harm Jan} and Yukinori Okada and Brenner, {Michael B.} and Soumya Raychaudhuri and Hendrickson, {Eric A.} and Maas, {Richard L.} and Nigrovic, {Peter A.}",
year = "2018",
month = "8",
day = "1",
doi = "10.1038/s41588-018-0159-z",
language = "English (US)",
volume = "50",
pages = "1180--1188",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction

AU - Li, Gang

AU - Martínez-Bonet, Marta

AU - Wu, Di

AU - Yang, Yu

AU - Cui, Jing

AU - Nguyen, Hung N.

AU - Cunin, Pierre

AU - Levescot, Anaïs

AU - Bai, Ming

AU - Westra, Harm Jan

AU - Okada, Yukinori

AU - Brenner, Michael B.

AU - Raychaudhuri, Soumya

AU - Hendrickson, Eric A.

AU - Maas, Richard L.

AU - Nigrovic, Peter A.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Genome-wide association studies (GWAS) have identified many disease-associated noncoding variants, but cannot distinguish functional single-nucleotide polymorphisms (fSNPs) from others that reside incidentally within risk loci. To address this challenge, we developed an unbiased high-throughput screen that employs type IIS enzymatic restriction to identify fSNPs that allelically modulate the binding of regulatory proteins. We coupled this approach, termed SNP-seq, with flanking restriction enhanced pulldown (FREP) to identify regulation of CD40 by three disease-associated fSNPs via four regulatory proteins, RBPJ, RSRC2 and FUBP-1/TRAP150. Applying this approach across 27 loci associated with juvenile idiopathic arthritis, we identified 148 candidate fSNPs, including two that regulate STAT4 via the regulatory proteins SATB2 and H1.2. Together, these findings establish the utility of tandem SNP-seq/FREP to bridge the gap between GWAS and disease mechanism.

AB - Genome-wide association studies (GWAS) have identified many disease-associated noncoding variants, but cannot distinguish functional single-nucleotide polymorphisms (fSNPs) from others that reside incidentally within risk loci. To address this challenge, we developed an unbiased high-throughput screen that employs type IIS enzymatic restriction to identify fSNPs that allelically modulate the binding of regulatory proteins. We coupled this approach, termed SNP-seq, with flanking restriction enhanced pulldown (FREP) to identify regulation of CD40 by three disease-associated fSNPs via four regulatory proteins, RBPJ, RSRC2 and FUBP-1/TRAP150. Applying this approach across 27 loci associated with juvenile idiopathic arthritis, we identified 148 candidate fSNPs, including two that regulate STAT4 via the regulatory proteins SATB2 and H1.2. Together, these findings establish the utility of tandem SNP-seq/FREP to bridge the gap between GWAS and disease mechanism.

UR - http://www.scopus.com/inward/record.url?scp=85049950726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049950726&partnerID=8YFLogxK

U2 - 10.1038/s41588-018-0159-z

DO - 10.1038/s41588-018-0159-z

M3 - Article

C2 - 30013183

AN - SCOPUS:85049950726

VL - 50

SP - 1180

EP - 1188

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 8

ER -